Sanofi, MannKind sign licensing agreement to develop and commercialize Afrezza Inhalation Powder

... activities. Under a separate supply agreement, MannKind will manufacture Afrezza at its manufacturing facility in Danbury, Connecticut. In addition, the companies are planning to collaborate to expand manufacturing capacity to meet global demand as ...



via Danbury Newswire http://ift.tt/1oWK4vp